Setting the scene - a future 'epidemic' of immune-related adverse events in association with checkpoint inhibitor therapy. (2019)

First Author: Bermudez MV
Attributed to:  Clinical Translation of Gene Modified T-cell Therapy for Solid Tumours funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kez402

PubMed Identifier: 31816083

Publication URI: http://europepmc.org/abstract/MED/31816083

Type: Journal Article/Review

Volume: 58

Parent Publication: Rheumatology (Oxford, England)

Issue: Suppl 7

ISSN: 1462-0324